Some Positive Stocks Overview (THQI, ACUR, IQNT, GALE)

New York, NY -- (SBWIRE) -- 11/30/2012 -- THQ Inc. (NASDAQ:THQI), is a worldwide developer and publisher of interactive entertainment software for game systems. THQ develops software for all game systems, including home video game consoles, such as the Microsoft Xbox 360 and Xbox 360 Kinect (Xbox 360), Nintendo Wii (Wii), and Sony PlayStation 3 (PS3), handheld platforms, such as the Nintendo DS, DSi and 3DS (DS), and Sony PlayStation Portable (PSP); wireless devices based on the Apple iOS (including the iPhone, iTouch and iPad), Google Android, and Windows Mobile platforms; personal computers (PCs), including games played online, and the Internet, including on social networking sites, such as Facebook.

THQ Inc. (NasdaqNM:THQI) is +0.41 - +37.96% from the previous close of $1.08. It traded between $1.11 - 1.58 with total traded volume of 1386540 shares. Keep a close eye on THQI, as the stock has been showing unusual moves over the past weeks. At Current market price, THQI has recovered +49.00% from its 52-week Low of 1.00 and has Pulled back -91.99% from its 52-week high of 18.60.

How Should Investors React To THQI Now? Find Out Here

Stocks of Acura Pharmaceuticals Inc. (NASDAQ:ACUR) have rised significantly on Friday, going up the as great as 2.60 with more than 1 thousand stocks trading hands by early mid-day. That 2.60 level symbolizes a three-month great for the specialized drug company and symbolizes a significant enhancement over the 52-week low of 1.06 set just nine days ago.

While stocks have since dropped returning down around the 2.10 level they are still well before 50-day going regular of 1.52 and stay within the vision of the 200-day going regular of 2.50. Thursday’s increase has come despite no news being launched by ACUR, providing the impact that traders had observed the business's stable go up returning from that 52-week low and decided to take the induce in large.

Should A Trader Buy Or Sell ACUR Now : CHECK HERE

Neutral Tandem, Inc. (NASDAQ:IQNT) , doing business as Inteliquent, incorporated on April 19, 2001, provides solutions for voice, data, and hosted services globally. With over 120 Ethernet sites across four continents, the Company is a global Ethernet interconnection provider, and has an Internet protocol version 6 network. Inteliquent is a network solutions provider, offering intelligent networking to solve interconnection and interoperability issues on a global scale.Share of IQNT is +0.64 - +28.83% from the previous close of $2.22. It traded between $2.2499 - 2.93 with total traded volume of 1587686 shares.At Current Market Price, IQNT is in distance of -41.22% from its 50-day Moving Average price of $4.8655 and -72.31% from its 200-day Moving Average price of $10.3301.

Should Investors Buy IQNT Now? Free Sign Up Here For IQNT Analyst Report

Galena Biopharma (Nasdaq:GALE), a medical company focused on creating impressive, focused oncology therapies dealing with major unmet medical needs to relocate melanoma care, these days declared two demonstrations at the 35th Yearly CTRC-AACR San Antonio Breasts Cancer Symposium. The occasion will be organized Dec 4-8, 2012 at the Gretchen B. Gonzalez Meeting Middle in San Antonio, Florida. Galena Biopharma, (NCM: GALE) is very effective these days and exchanged between $1.87 - 2.10 with complete exchanged numbers of 4522877 stocks. At a present cost of 2.04, GALE is +0.25 - +13.97% for the past near of $1.79. Moreover, At Current Industry Price, GALE is in the range of +8.23% from its 50-day Going Regular cost of $1.8849 and +20.88% from its 200-day Going Regular cost of $1.6877.

For a FREE GALE Specialized Research, please check out

DISCLAIMER:

Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz